Controversies surrounding the diagnosis of schizophrenia and other psychoses

Expert Review of Neurotherapeutics

Volumn 9, Issue 10, 2009, Pages 1475-1486

  Cuesta, Manuel J ^a   Basterra, Virginia ^a   Sanchez Torres, Ana ^a   Peralta, Victor ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Diagnostic issues; Phenome wide scanning; Psychopathology; Psychosis; Schizophrenia

Indexed keywords

ANXIETY DISORDER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; INTERVIEW; MOOD DISORDER; NEUROBIOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOSIS; RELIABILITY; REVIEW; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOMATOLOGY; VALIDITY;

HUMANS; MENTAL DISORDERS; MODELS, PSYCHOLOGICAL; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 70350150812     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.102     Document Type: Review

References (138)

1. Freedman R. Schizophrenia. N. Engl. J. Med. 349(18), 1738-1749 (2003).
2. Thaker GK, Carpenter WT Jr. Advances in schizophrenia. Nat. Med. 7(6), 667-671 (2001).
3. Jablensky A. Boundaries of mental disorders. Curr. Opin. Psychiatry 18(6), 653-658 (2005).
4. Picchioni MM, Murray RM. Schizophrenia. BMJ 335(7610), 91-95 (2007).
5. Rittmannsberger H. Polypharmacy in psychiatric inpatient treatment. Am. J. Psychiatry 161(4), 761 (2004).
6. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease study. Science 274(5288), 740-743 (1996).
7. Andlin-Sobocki P, Rossler W. Cost of psychotic disorders in Europe. Eur. J. Neurol. 12(Suppl. 1), 74-77 (2005).
8. WHO. Report of the International pilot study of Schizophrenia VIG, Switzerland, World Health Organization, Geneva, Switzerland (1973).
9. Perälä J, Suvisaari J, Saarni SI et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 64(1), 19-28 (2007). (Pubitemid 46041735)
10. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 30, 67-76 (2008).
11. Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog. Brain Res. 147, 319-345 (2005). (Pubitemid 39582800)
12. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10(1), 40-68 (2005).
13. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10(5), 434-449 (2005).
14. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron 52(1), 139-153 (2006).
15. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 196(4286), 129-136 (1977).
16. Zubin J, Spring B. Vulnerability - a new view of schizophrenia. J. Abnorm. Psychol. 86(2), 103-126 (1977).
17. Sullivan PF. Spurious genetic associations. Biol. Psychiatry 61(10), 1121-1126 (2007).
18. McGuffin P, Farmer AE, Gottesman II, Murray RM, Reveley AM. Twin concordance for operationally defined schizophrenia: confirmation of familiality and heritability. Arch. Gen. Psychiatry 41(6), 541-545 (1984). (Pubitemid 14111382)
19. Burmeister M, McInnis MG, Zollner S. Psychiatric genetics: progress amid controversy. Nat. Rev. Genet. 9(7), 527-540 (2008). (Pubitemid 351972757)
20. Morrison A, Read J, Turkington D. Trauma and psychosis: theoretical and clinical implications. Acta Psychiatr. Scand. 112(5), 327-329 (2005). (Pubitemid 41564318)
21. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 52(12), 1048-1060 (1995).
22. Shaw K, McFarlane A, Bookless C. The phenomenology of traumatic reactions to psychotic illness. J. Nerv. Ment. Dis. 185(7), 434-441 (1997). (Pubitemid 27313835)
23. Tanskanen A, Hintikka J, Honkalampi K, Haatainen K, Koivumaa-Honkanen H, Viinamaki H. Impact of multiple traumatic experiences on the persistence of depressive symptoms - a population-based study. Nord. J. Psychiatry 58(6), 459-464 (2004). (Pubitemid 39642518)
24. Morrison AP, Frame L, Larkin W. Relationships between trauma and psychosis: a review and integration. Br. J. Clin. Psychol. 42(Pt 4), 331-353 (2003). (Pubitemid 37526830)
25. Read J, van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr. Scand. 112(5), 330-350 (2005). (Pubitemid 41564319)
26. Janssen I, Krabbendam L, Bak M et al. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr. Scand. 109(1), 38-45 (2004). (Pubitemid 38161099)
27. Whitfield CL, Dube SR, Felitti VJ, Anda RF. Adverse childhood experiences and hallucinations. Child Abuse Negl. 29(7), 797-810 (2005).
28. Read J, Agar K, Argyle N, Aderhold V. Sexual and physical abuse during childhood and adulthood as predictors of hallucinations, delusions and thought disorder. Psychol. Psychother. 76(Pt 1), 1-22 (2003).
29. Schenkel LS, Spaulding WD, DiLillo D, Silverstein SM. Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits. Schizophr. Res. 76(2-3), 273-286 (2005). (Pubitemid 40804773)
30. Shevlin M, Murphy J, Dorahy MJ, Adamson G. The distribution of positive psychosis-like symptoms in the population: a latent class analysis of the National Comorbidity Survey. Schizophr. Res. 89(1-3), 101-109 (2007). (Pubitemid 44881308)
31. Moffitt TE, Caspi A, Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch. Gen. Psychiatry 62(5), 473-481 (2005). (Pubitemid 40637222)
32. Kendler KS. "A gene for...": the nature of gene action in psychiatric disorders. Am. J. Psychiatry 162(7), 1243-1252 (2005).
33. van Os J, Rutten BP, Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull. 34(6), 1066-1082 (2008).
34. Hardy J, Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 360(17), 1759-1768 (2009).
35. Ramocki MB, Zoghbi HY. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 455(7215), 912-918 (2008).
36. Yuwiler A. Diagnosis and the hunt for etiology. Biol. Psychiatry 37(1), 1-3 (1995).
37. Peralta V, Cuesta MJ. Clinical models of schizophrenia: a critical approach to competing conceptions. Psychopathology 33(5), 252-258 (2000). (Pubitemid 30759388)
38. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am. J. Psychiatry 151(10), 1409-1416 (1994). (Pubitemid 24301683)
39. Modestin J, Huber A, Satirli E, Malti T, Hell D. Long-term course of schizophrenic illness: Bleuler's study reconsidered. Am. J. Psychiatry 160(12), 2202-2208 (2003). (Pubitemid 39619614)
40. Salvatore P, Tohen M, Khalsa HM, Baethge C, Tondo L, Baldessarini RJ. Longitudinal research on bipolar disorders. Epidemiol. Psichiatr. Soc. 16(2), 109-117 (2007).
41. Pope HG Jr, Lipinski JF Jr. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch. Gen. Psychiatry 35(7), 811-828 (1978).
42. Cuesta MJ, Peralta V. Current psychopathological issues in psychosis: towards a phenome-wide scanning approach. Schizophr. Bull. 34(4), 587-590 (2008). (Pubitemid 351957562)
43. Peralta V, Cuesta MJ. Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br. J. Psychiatry 174, 243-248 (1999). (Pubitemid 29147240)
44. Cuesta MJ, Peralta V. Does formal thought disorder differ among patients with schizophrenic, schizophreniform and manic schizoaffective disorders? Schizophr. Res. 10(2), 151-158 (1993). (Pubitemid 23273368)
45. Cuesta MJ, Peralta V. Thought disorder in schizophrenia. Testing models through confirmatory factor analysis. Eur. Arch. Psychiatry Clin. Neurosci. 249(2), 55-61 (1999). (Pubitemid 29366762)
46. Peralta V, Cuesta MJ, Martinez-Larrea A, Serrano JF. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am. J. Psychiatry 157(9), 1461-1466 (2000). (Pubitemid 30677139)
47. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry 145(5), 578-583 (1988).
48. Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr. Bull. DOI: 10.1093/schbul/sbn094 (2008) (Epub ahead of print).
49. Cuesta MJ, Peralta V. Are positive and negative symptoms relevant to crosssectional diagnosis of schizophrenic and schizoaffective patients? Compr. Psychiatry 36(5), 353-361 (1995).
50. Carroll BJ. Symptoms do not helpfully distinguish unipolar and bipolar depression. Br. J. Psychiatry 193(5), 426 (2008).
51. Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr. Bull. 33(4), 886-892 (2007). (Pubitemid 47216658)
52. Peralta V, Cuesta MJ. Characterization of affective domains within the nonaffective psychotic disorders. Schizophr. Res. 111(1-3), 61-69 (2009).
53. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) American Psychiatric Association, DC, USA (2000).
54. Cuesta MJ, Ugarte MD, Goicoa T, Eraso S, Peralta V. A taxometric analysis of schizophrenia symptoms. Psychiatry Res. 150(3), 245-253 (2007).
55. Lieberman DZ, Peele R, Razavi M. Combinations of DSM-IV-TR criteria sets for bipolar disorders. Psychopathology 41(1), 35-38 (2008). (Pubitemid 350146911)
56. van Os J, Driessen G, Gunther N, Delespaul P. Neighbourhood variation in incidence of schizophrenia. Evidence for person-environment interaction. Br. J. Psychiatry 176, 243-248 (2000). (Pubitemid 30179843)
57. Verdoux H, van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res. 54(1-2), 59-65 (2002). (Pubitemid 34164519)
58. Eaton WW. Update on the epidemiology of schizophrenia. Epidemiol. Rev. 13, 320-328 (1991).
59. Tien AY. Distributions of hallucinations in the population. Soc. Psychiatry Psychiatr. Epidemiol. 26(6), 287-292 (1991).
60. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity survey. Br. J. Psychiatry 188, 519-526 (2006). (Pubitemid 43844098)
61. Peralta V, Cuesta MJ. The underlying structure of diagnostic systems of schizophrenia: a comprehensive polydiagnostic approach. Schizophr. Res. 79(2-3), 217-229 (2005). (Pubitemid 41457262)
62. Jansson LB, Parnas J. Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr. Bull. 33(5), 1178-1200 (2007). (Pubitemid 47351232)
63. Jablensky A. The conflict of the nosologists: views on schizophrenia and manic-depressive illness in the early part of the 20th century. Schizophr. Res. 39(2), 95-100; discussion 159 (1999). (Pubitemid 29415680)
64. Berrios GE. The History of Mental Symptoms. Cambridge University Press, Cambridge, UK (1996).
65. Berrios GE, Porter R. A History of Clinical Psychiatry. The Origin and History of Psychiatric Disorders. Athlone, London, UK (1995).
66. Greene T. The Kraepelinian dichotomy: the twin pillars crumbling? Hist. Psychiatry 18(71 Pt 3), 361-379 (2007).
67. Healy D, Harris M, Farquhar F, Tschinkel S, Le Noury J. Historical overview: Kraepelin's impact on psychiatry. Eur. Arch. Psychiatry Clin. Neurosci. 258(Suppl. 2), 18-24 (2008). (Pubitemid 351758754)
68. Hippius H, Muller N. The work of Emil Kraepelin and his research group in Munchen. Eur. Arch. Psychiatry Clin. Neurosci. 258(Suppl. 2), 3-11 (2008). (Pubitemid 351758752)
69. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol. Psychiatry 11(9), 815-836 (2006). (Pubitemid 44299104)
70. Kendell RE, Brockington IF. The identification of disease entities and the relationship between schizophrenic and affective psychoses. Br. J. Psychiatry 137, 324-331 (1980).
71. van Os J, Tamminga C. Deconstructing psychosis. Schizophr. Bull. 33(4), 861-862 (2007).
72. Craddock N, Owen MJ. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry 6(2), 84-91 (2007). (Pubitemid 47019293)
73. Regier DA. Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introduction. Int. J. Methods Psychiatr. Res. 16(Suppl. 1), S1-S5 (2007).
74. Gaebel W, Zielasek J. Psychiatry as a diagnostic discipline. Eur. Arch. Psychiatry Clin. Neurosci. 258(Suppl. 5), 1 (2008).
75. Correll CU, Smith CW, Auther AM et al. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J. Child Adolesc. Psychopharmacol. 18(5), 475-490 (2008).
76. Peralta V, Cuesta MJ. A dimensional and categorical architecture for the classification of psychotic disorders. World Psychiatry 6(2), 100-101 (2007).
77. Peralta V, Cuesta MJ, Zandio M. Cycloid psychosis: an examination of the validity of the concept. Curr. Psychiatry Rep. 9(3), 184-192 (2007). (Pubitemid 46895095)
78. Peralta V, Cuesta MJ. Cycloid psychosis. Int. Rev. Psychiatry 17(1), 53-62 (2005).
79. Siris SG, Addington D, Azorin JM, Falloon IR, Gerlach J, Hirsch SR. Depression in schizophrenia: recognition and management in the USA. Schizophr. Res. 47(2-3), 185-197 (2001). (Pubitemid 32244103)
80. Keck PE Jr, McElroy SL, Havens JR et al. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr. Psychiatry 44(4), 263-269 (2003).
81. Kempf L, Hussain N, Potash JB. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int. Rev. Psychiatry 17(1), 9-19 (2005). (Pubitemid 40591403)
82. Zimmerman M, Chelminski I. Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct? Am. J. Psychiatry 160(3), 504-512 (2003). (Pubitemid 41094259)
83. Bermanzohn PC, Porto L, Arlow PB, Pollack S, Stronger R, Siris SG. Hierarchical diagnosis in chronic schizophrenia: a clinical study of cooccurring syndromes. Schizophr. Bull. 26(3), 517-525 (2000). (Pubitemid 30680475)
84. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 35(2), 383-402 (2009).
85. Marneros A, Deister A, Rohde A. Comparison of long-term outcome of schizophrenic, affective and schizoaffective disorders. Br. J. Psychiatry Suppl. 18, 44-51 (1992).
86. Schwartz JE, Fennig S, Tanenberg-Karant M et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch. Gen. Psychiatry 57(6), 593-600 (2000). (Pubitemid 30349440)
87. Forrester A, Owens DG, Johnstone EC. Diagnostic stability in subjects with multiple admissions for psychotic illness. Psychol. Med. 31(1), 151-158 (2001). (Pubitemid 32046745)
88. Salvatore P, Baldessarini RJ, Tohen M et al. McLean-Harvard international first-episode project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J. Clin. Psychiatry 70(4), 458-466 (2009).
89. Baca-Garcia E, Perez-Rodriguez MM, Basurte-Villamor I et al. Diagnostic stability of psychiatric disorders in clinical practice. Br. J. Psychiatry 190, 210-216 (2007). (Pubitemid 46384004)
90. Kendler KS. Explanatory models for psychiatric illness. Am. J. Psychiatry 165(6), 695-702 (2008).
91. Cuesta MJ, Peralta V. Psychopathological dissection of schizophrenia and major mood disorders: relevance for classification. Curr. Psychiatry Rep. 11(4), 324-331 (2009).
92. Fanous AH, van den Oord EJ, Riley BP et al. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am. J. Psychiatry 162(10), 1824-1832 (2005).
93. Cook EH Jr, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 455(7215), 919-923 (2008).
94. Ivleva E, Thaker G, Tamminga CA. Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr. Bull. 34(4), 734-742 (2008). (Pubitemid 351957570)
95. Lichtenstein P, Yip BH, Bjork C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373(9659), 234-239 (2009).
96. Owen MJ, Craddock N. Diagnosis of functional psychoses: time to face the future. Lancet 373(9659), 190-191 (2009).
97. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder: same genes, (partly) different environments? Arch. Gen. Psychiatry 49(9), 716-722 (1992).
98. Kendler KS, Karkowski-Shuman L, Walsh D. Age at onset in schizophrenia and risk of illness in relatives: results from the Roscommon Family study. Br. J. Psychiatry 169(2), 213-218 (1996). (Pubitemid 126735165)
99. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am. J. Psychiatry 159(4), 539-545 (2002). (Pubitemid 34274934)
100. Vassos E, Sham PC, Cai G et al. Correlation and familial aggregation of dimensions of psychosis in affected sibling pairs from China. Br. J. Psychiatry 193(4), 305-310 (2008).
101. Dikeos DG, Wickham H, McDonald C et al. Distribution of symptom dimensions across Kraepelinian divisions. Br. J. Psychiatry 189, 346-353 (2006). (Pubitemid 44606748)
102. DeRosse P, Funke B, Burdick KE et al. Dysbindin genotype and negative symptoms in schizophrenia. Am. J. Psychiatry 163(3), 532-534 (2006). (Pubitemid 44469399)
103. Burdick KE, Goldberg TE, Funke B et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res. 89(1-3), 169-172 (2007). (Pubitemid 44881303)
104. DeRosse P, Lencz T, Burdick KE, Siris SG, Kane JM, Malhotra AK. The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia. Schizophr. Bull. 34(6), 1047-1053 (2008).
105. Kendler KS, Karkowski LM, Walsh D. The structure of psychosis: latent class analysis of probands from the Roscommon Family study. Arch. Gen. Psychiatry 55(6), 492-499 (1998). (Pubitemid 28272292)
106. DeLisi LE. A new classification for the psychoses? Arch. Gen. Psychiatry 56(7), 672-673 (1999).
107. Peralta V, Cuesta MJ. Familial liability and schizophrenia phenotypes: a polydiagnostic approach. Schizophr. Res. 96(1-3), 125-134 (2007). (Pubitemid 47494642)
108. Cannon TD, van Erp TG, Rosso IM et al. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 59(1), 35-41 (2002).
109. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 309(6956), 699-703 (1994). (Pubitemid 24285221)
110. van Os J, Jones P, Lewis G, Wadsworth M, Murray R. Developmental precursors of affective illness in a general population birth cohort. Arch. Gen. Psychiatry 54(7), 625-631 (1997). (Pubitemid 27306572)
111. Jones PB, Tarrant CJ. Specificity of developmental precursors to schizophrenia and affective disorders. Schizophr. Res. 39(2), 121-125 (1999).
112. Van Os J, Gilvarry C, Bale R et al. A comparison of the utility of dimensional and categorical representations of psychosis: UK700 group. Psychol. Med. 29(3), 595-606 (1999). (Pubitemid 29261347)
113. Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM. Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr. Bull. 33(4), 868-876 (2007). (Pubitemid 47216660)
114. Allardyce J, McCreadie RG, Morrison G, van Os J. Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Soc. Psychiatry Psychiatr. Epidemiol. 42(6), 429-437 (2007). (Pubitemid 46887813)
115. Reichenberg A, Weiser M, Rabinowitz J et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am. J. Psychiatry 159(12), 2027-2035 (2002). (Pubitemid 35423861)
116. Cannon M, Caspi A, Moffitt TE et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch. Gen. Psychiatry 59(5), 449-456 (2002). (Pubitemid 34477681)
117. Thompson PM, Vidal C, Giedd JN et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl Acad. Sci. USA 98(20), 11650-11655 (2001). (Pubitemid 32928783)
118. McDonald C, Bullmore ET, Sham PC et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch. Gen. Psychiatry 61(10), 974-984 (2004). (Pubitemid 39336530)
119. Shields J, Gottesman, II. Cross-national diagnosis of schizophrenia in twins: the heritability and specificity of schizophrenia. Arch. Gen. Psychiatry 27(6), 725-730 (1972).
120. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160(4), 636-645 (2003).
121. Thaker G. Psychosis endophenotypes in schizophrenia and bipolar disorder. Schizophr. Bull. 34(4), 720-721 (2008). (Pubitemid 351957568)
122. Lin PI, Mitchell BD. Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder. Schizophr. Bull. 34(4), 791-797 (2008).
123. Hill SK, Harris MS, Herbener ES, Pavuluri M, Sweeney JA. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr. Bull. 34(4), 743-759 (2008). (Pubitemid 351957555)
124. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3), 426-445 (1998).
125. Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res. 58(3), 227-235 (1995).
126. Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J. Clin. Psychiatry 67(10), e12 (2006).
127. Keefe RS, Fenton WS. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr. Bull. 33(4), 912-920 (2007).
128. David AS, Zammit S, Lewis G, Dalman C, Allebeck P. Impairments in cognition across the spectrum of psychiatric disorders: evidence from a Swedish conscript cohort. Schizophr. Bull. 34(6), 1035-1041 (2008).
129. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr. Res. 80(2-3), 137-149 (2005). (Pubitemid 41713640)
130. Daban C, Martinez-Aran A, Torrent C et al. Specificity of cognitive deficits in bipolar disorder versus schizophrenia: a systematic review. Psychother. Psychosom. 75(2), 72-84 (2006). (Pubitemid 43313376)
131. Reichenberg A, Harvey PD, Bowie CR et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr. Bull. 35(5), 1022-1029 (2009).
132. Cuesta MJ, Peralta V, Zarzuela A. Empirical validation of competing definitions of schizophrenia: a polydiagnostic study of cognitive impairment in non-affective psychosis. Schizophr. Res. 95(1-3), 39-47 (2007). (Pubitemid 47313657)
133. Kendler KS. Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am. J. Psychiatry 163(7), 1138-1146 (2006).
134. Cuesta MJ, Peralta V. Integrating psychopathological dimensions in functional psychoses: a hierarchical approach. Schizophr. Res. 52(3), 215-229 (2001). (Pubitemid 33052511)
135. Sato M. Renaming schizophrenia: a Japanese perspective. World Psychiatry 5(1), 53-55 (2006).
136. O'Sullivan D, Pell M. Long-term follow-up of DBS of thalamus for tremor and STN for Parkinson's disease. Brain Res. Bull. 78(2-3), 119-121 (2009).
137. Collip D, Myin-Germeys I, Van Os J. Does the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr. Bull. 34(2), 220-225 (2008). (Pubitemid 351323342)
138. van Os J. A salience dysregulation syndrome. Br. J. Psychiatry 194(2), 101-103 (2009).